Sign in

    Katarina Markovic

    Research Analyst at JPMorgan Chase & Co.

    Katarina Markovic is an Executive Director and Alternative Investments Specialist at J.P. Morgan Wealth Management, focusing on portfolio positioning with hedge funds, private equity, venture capital, and real estate for clients across the Western region. Over a 25-year career, she has worked with leading alternative investment managers and previously held senior business development and investor relations roles at Sachs Capital Group, RD Legal Capital, LKS Capital, and Epsilon Investment Management, as well as founding her own consultancy. She joined J.P. Morgan in 2022 after starting her finance career at Merrill Lynch in 1996, earning both a B.S. in International Economics from Marymount College and an M.B.A. in Finance and Marketing from Rollins College. Markovic is recognized for her deep expertise in alternative assets, though specific performance metrics, company coverage details, and securities registration are not publicly disclosed.

    Katarina Markovic's questions to IDEXX LABORATORIES INC /DE (IDXX) leadership

    Katarina Markovic's questions to IDEXX LABORATORIES INC /DE (IDXX) leadership • Q1 2025

    Question

    Katarina Markovic, on for Chris Schott, inquired about the overall health of U.S. pet owner demand amid economic uncertainty and asked for details on the company's exposure to tariffs and its mitigation strategies.

    Answer

    Executive Andrew Emerson acknowledged pressure on clinical visits, especially for elective procedures, but stated this is factored into the company's outlook and offset by strong diagnostic utilization. On tariffs, he explained that with 65% of revenue being U.S.-based and less than 1% from China, the company is well-positioned. CEO Jay Mazelsky added that the 'local-for-local' model of their global reference labs and a focus on supply chain resilience further mitigate tariff impacts.

    Ask Fintool Equity Research AI